1-3 of 3
transcription mediated amplification
Close
Sort by
Journal Articles

Clinical Entity and Outcomes of Therapy-Related Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: Surveillance By the Chronic Myeloid Leukemia Cooperative Study Group

Noriyoshi Iriyama, MDPhD, Tomoiku Takaku, MD, PhD, Eriko Sato, Maho Ishikawa, Tomonori Nakazato, Kei-Ji Sugimoto, MD PhD, Hiroyuki Fujita, MD PhD, Michihide Tokuhira, MD PhD, Tatsuya Kawaguchi, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3084.
https://doi.org/10.1182/blood.V128.22.3084.3084
Published: 2016
Journal Articles

Sustained Molecular Response with Maintenance Dose of Interferon Alfa After Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia

Kensuke Usuki, MD, PhD, Nozomi Yusa, Akira Hangaishi, MD, PhD, Rieko Sekine, MD, PhD, Kenshi Suzuki, MD, PhD, Shinya Kimura, MD, PhD, Arinobu Tojo, MD, PhD.
Journal: Blood
Blood (2012) 120 (21): 1684.
https://doi.org/10.1182/blood.V120.21.1684.1684
Published: 2012
Journal Articles

Detection of BCR-ABL Transcript by Quantitative Real-Time PCR and Amp-CML (Transcript Mediated Amplification) during Imatinib Therapy for Chronic Myeloid Leukemia.

Koichi Miyamura, Fumiharu Yagasaki, Taiichi Kyo, Kazunori Ohnishi, Tomoki Naoe, Hitoshi Takeuchi, Miki Nishimura, Shin Fujiwara, Tetsuzo Tauchi, Ryuzo Ohno
Journal: Blood
Blood (2006) 108 (11): 4791.
https://doi.org/10.1182/blood.V108.11.4791.4791
Published: 2006